4 May 2022

Ridgway, Harry, Moore, Graham J, Mavromoustakos, Thomas, Tsiodras, Sotirios, Ligielli, Irene, Kelaidonis, Konstantinos, Chasapis, Christos T, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Petty, Russell, Karakasiliotis, Ioannis, Gorgoulis, Vassilis G and Matsoukas, John ORCID: 0000-0001-5554-2964 (2022) Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Computational and Structural Biotechnology Journal, 20. pp. 2091-2111. ISSN 2001-0370

22 January 2023

Ridgway, Harry, Ntallis, Charalampos ORCID: 0000-0002-4189-5803, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Plotas, Panagiotis, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Moore, Graham, Tsiodras, Sotirios ORCID: 0000-0002-0463-4321, Paraskevis, Dimitrios ORCID: 0000-0001-6167-7152, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X and Matsoukas, John ORCID: 0000-0001-5554-2964 (2023) Molecular epidemiology of SARS-CoV-2: the dominant role of arginine in mutations and infectivity. Viruses, 15 (2). ISSN 1999-4915

2024

Ridgway, Harry, Moore, Graham J, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Hoffmann, Weronika, Węgrzyn, Katarzyna, Vassilaki, Niki, Mpekoulis, George, Zouridakis, Marios, Giastas, Petros, Vidali, Veroniki P ORCID: 0000-0001-9020-8726, Kelaidonis, Konstantinos, Matsoukas, Minos-Timotheos ORCID: 0000-0002-4642-8163, Dimitriou, Marios, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X, Tsiodras, Sotirios ORCID: 0000-0002-0463-4321, Gorgoulis, Vassilis G, Karakasiliotis, Ioannis, Chasapis, Christos T ORCID: 0000-0002-8728-6245 and Matsoukas, John ORCID: 0000-0001-5554-2964 (2024) Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies. Expert Opinion on Therapeutic Targets, 28 (5). pp. 437-459. ISSN 1472-8222